Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients With Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy

Asian Pacific Journal of Cancer Prevention
doi 10.31557/apjcp.2019.20.10.2995
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EpiSmart Science Vector Ltd

Related search

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy
2013English

No Evidence for Changes in Skeletal Muscle Mass or Weight During First-Line Chemotherapy for Metastatic Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2020English

FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2018English

Role of Pretreatment Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy

Erciyes Medical Journal
Medicine
2019English

Could Salvage Surgery After Chemotherapy Have Clinical Impact on Cancer Survival of Patients With Metastatic Urothelial Carcinoma?

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2011English

Pcn178 - Cost-Effectiveness of Pembrolizumab as Second-Line Treatment for Patients With Advanced Urothelial Cancer in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy